Supervisory Board

  • Dharminder Chahal
    Dharminder Chahal

    Dharminder Chahal has built an extensive network in the life science industry and a strong track record in complex corporate transactions. These include the sale of the stake of Van Herk Investments in Crucell to Johnson and Johnson, the sale of deVGen to Syngenta and the sale of Octoplus to Dr. Reddy’s. As a CEO, board member or advisor he is active for several European companies such as SkylineDx, CardioGenx, BioInvent, VitalneXt, BioGeneration Ventures II, Thuja Capital Fund I, Gilde Healthcare Funds II and III and Innate Pharma.

  • Andre Goig
    Andre Goig

    Mr. André Goig is chairman of the Board of Supervisors of Ceradis B.V. as of May 18, 2015. Having started his professional career as a Financial Analyst, André Goig has held numerous European financial and general management positions for companies such as Price Waterhouse, Dana Corporation and Pennwalt Corporation. Joining Sandoz in 1988 as Managing Director of Sandoz Agro in France, André subsequently assumed several leadership positions for Syngenta’s legacy companies, including Corporate Head of Strategic Products & Controlling (Crop Protection) and Head of Seeds EAME. In 2004, he was appointed to the position of Global Head of Vegetables while keeping his Seeds EAME regional role. Following Syngenta’s reorganisation early 2011, he was appointed Regional Director EAME for Syngenta Crop Protection and Seeds activities.André obtained a degree in Economics from ISG Business School in Paris before attending various advanced Executive Education programs at Harvard University and Northwestern University. He is a Board member of ESA (European Seeds Association) and of EuropaBio (biotech industry at the EU level), as well as the Chairman of its Agri-Food council.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Vul je zoekopdracht in.